Findings from the VA’s Diuretic Comparison Project show pragmatic trial designs can achieve strong provider participation when burden is minimized and patient care remains the primary focus.

Randomized, placebo-controlled Phase 2a study of SPL026 met its primary endpoint demonstrating a clinically significant reduction in depressive ...

A lung cancer trial bolsters a long-held idea that treatment timing matters, showing a simple shift could help immunotherapy ...

Patient-reported outcome measures and clinical scales were ineffective in predicting responses to full-agonist opioids for chronic pain.

Ketogenic diets do show promise for schizophrenia and bipolar disorder, but the research is preliminary and not backed by randomized controlled trials.

Google DeepMind CEO Demis Hassabis on Wednesday (February 18) said a new era of scientific discovery driven by AI is on the ...

A common clinical question for medical oncologists treating metastatic castration-resistant prostate cancer is, should patients who previously received docetaxel and progress on it, reuse docetaxel or ...

During a live event, Hagen Kennecke, MD, discusses how RADIANT-4 and NETTER trials have reshaped NET care with everolimus and PRRT.

Prostate cancer has been of the major areas of research for radioligand therapies. Last year, Novartis officials estimated that the March 28, 2025, FDA approval for Pluvicto in metastatic ...

Not only can the drug metformin help to effectively manage type 2 diabetes, but it may also give older women a better chance ...

A new review fails to find much of any added weight loss benefit from intermittent fasting compared to typical diet advice.

Yet, importantly, Medicare beneficiaries aren’t covered when services are provided by pharmacists. These policies leave ...